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e-mail address: monaabdelkader78@yahoo.comMona Abdelkader, MD ⇑AbstractPurpose: To identify local retinal abnormalities and evaluate the nature and extent of retinal dysfunction in diabetics using full field
electroretinogram (ERG) and multifocal ERG (MF-ERG) and to determine the correlation between features of optical coherence
tomography (OCT) and MF-ERG.
Methods: Twenty-eight normal subjects (Control Group; 56 eyes) and 37 patients (72 eyes) with diabetes mellitus (DM Group)
were evaluated. In the DM Group, 17 eyes had no retinopathy (grade 1), 18 eyes had early non proliferative diabetic retinopathy
(NPDR) (grade 3), 16 eyes had late NPDR (grade 4), 21 eyes had proliferative diabetic retinopathy (PDR) (grade 5). Full field ERG
and MF-ERG, were used to assess the effects of diabetic retinopathy on retinal function. OCT and fluorescein angiography were
used to assess and compare morphological changes with functional changes in diabetes mellitus.
Results: In diabetic patients without retinopathy (17 eyes), the amplitudes of the second order component of MF-ERG were
reduced and implicit times were delayed, while only implicit times of first order component of MF-ERG were delayed but the
amplitudes of first order component were normal. In diabetic patients with retinopathy (55 eyes), the overall amplitudes were
reduced and peak implicit time increased in the first order component and second order component.
OCT of the DM Group showed the fovea of eyes with edema were thicker than the Normal Group. The fovea of eyes with cystoid
macular edema (CME) were significantly thicker than the fovea of eyes with diffuse swelling. The implicit times of MF-ERG were
directly correlated with foveal thickness.
Conclusion: MF-ERG reveals local retinal dysfunction in diabetic patients. MF-ERG offers the advantage of topographic mapping
of retinal dysfunction. The magnitude of delay of MF-ERG implicit time reflects the degree of local clinical abnormalities in eyes
with retinopathy. Local response delays found in eyes without retinopathy detects subclinical local retinal dysfunction in diabetics.
The combination of OCT and MF-ERG may provide objective criteria for evaluation and assessment of diabetic retinopathy.
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 2012 Saudi Ophthalmological Society, King Saud University. All rights reserved.
http://dx.doi.org/10.1016/j.sjopt.2012.03.003Introduction
Diabetic retinopathy is a leading cause of blindness
among individuals in the working age group in the United
States.1 Visual loss is generally irreversible once non perfu-
sion regions, neovascularization or both are clearly identified
by ophthalmoscopy and fluorescein angiography.2
The evaluation of the functional properties of the diabetic
retina with objective methods such as electroretinogram
(ERG) is an important aspect of the diagnostic and therapeu-tic approach to diabetic retinopathy.3 The full field ERG has
been used as an objective tool to detect alterations of retinal
function during early stages of diabetes mellitus,4 to predict
progression of diabetic retinopathy,5 and to monitor treat-
ment effects.6 However the sensitivity of full-field ERG is lim-
ited, because it reflects the activity of the entire retina. Even
advanced disease, if confined to small discrete patches can
remain undetected by full field ERG.7
In diabetes mellitus, the earliest clinical changes are typi-
cally confined to the posterior pole.8 Therefore, the abilitye:
al.com
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objective detection of early functional alterations and assess-
ment of local changes over time. Focal ERG has been used to
evaluate retinal function within the macula (central 3–10) in
diabetic patients.9 However, the technique is too time con-
suming to allow testing of even a few retinal areas during
one session. In contrast, MF-ERG was developed by Sutter
and Tran10 enables assessment of up to hundreds of distinct
retinal regions within approximately 8 min per eye.11 MF-
ERG is an objective technique for mapping retinal function.
Functional abnormalities preceding retinal disease and
changes associated with retinal disease have been studied
with MF-ERG, an objective technique for mapping retinal
function.11,12
The purpose of this study was to explore the efficacy
of MF-ERG in detecting and localizing dysfunctional reti-
nal areas in diabetes and to compare the features of
optical coherence tomography (OCT) and MF-ERG
outcomes.Methods
Subjects for this study were enrolled from patients pre-
senting to the outpatient clinic of Mansoura Ophthalmic Cen-
ter from January 2009 to May 2010. Subjects were enrolled
into one of two groups: 28 normal subjects (Control Group)
and; 37 diabetic patients (DM Group). All eyes had 20/40
or better corrected visual acuity with refractive error between
1.00D and +1.00D. Patients with visible media opacities or
a history of other ocular disease or surgery were excluded
from the study.
The level of diabetic retinopathy and degree of macular
edema were diagnosed by dilated eye examination, slit lamp
biomicroscopy, direct and indirect ophthalmoscopy, and
photography and fluorescein angiography).
All subjects underwent full ophthalmic examination, full
field ERG, MF-ERG and OCT. All control subjects had no
known abnormalities of the visual system, normal findings in
ophthalmic examination, normal full field ERG, normal MF-
ERG and normal OCT features.
This study was approved by the Human Subjects Commit-
tee of the University of Mansoura, and adhered to the Decla-
ration of Helsinki. The purpose and potential risks of the
study were explained to the subjects and written informed
consent was obtained from all participants.ERG
Full field ERG and MF-ERG were recorded using Roland
Consult (Roland Consult, Elektrophysiologische Diagnostik
Systeme, Brandenburg, Germany). Pupils were fully dilated
(P7 mm) using 1% tropicamide and 2.5% phenylephrine.
Before placing electrodes, the skin was cleansed. Topical
corneal anesthesia (Benoxinate hydrochloride 4%) was in-
stilled and a Dawson, Trick and Litzkow (DTL) electrode (po-
sitive electrode) was placed contacting corneal limbus, a
ground electrode was placed on the forehead and a nega-
tive electrode was placed near the orbital rim. The elec-
trodes were placed under dim red light and after dark
adaption for 20 min. The recording was monocular and
the contralateral eye was occluded with light pressure to
suppress blinking.Full field ERG
Prior to beginning the patients had to in a comfortable
body position, the head was still before stimulation and the
eyes fixated on red light within the Ganzfeld globe. Subse-
quently the test was started and recorded in 5 steps: scotopic
rod response, scotopic combined response, oscillatory po-
tential then light adaptation for 10 min then photopic cone
response and flicker response recording.MF-ERG
Patients were positioned 30 cm from the stimulus monitor.
Stimulus clarity was optimized by overrefraction and the final
adjustment of the test distance was made to maintain con-
stant stimulus magnification. The stimulus was presented on
a 32 cm  22 cm monitor driven at a 75 Hz frame rate and
consisted of an array of 61 hexagonal elements across a field
subtending 44 horizontally and 40 vertically. White hexa-
gons had a luminance of 185–200 cd/m2 and dark frames
were 1–2 cd/m2 resulting in local contrast of 98–99%. Each
hexagon was temporally modulated between light and dark
according to a binary m-squence.10 At any time, approxi-
mately 50% of the stimulus elements displayed were white
and 50% were black. Observers fixated on a small gray spot
in the center of the stimulus during 8-min recording sessions.
To improve fixation stability, the sessions were divided into
30 s segments with brief rest periods between each segment.
Signals were amplified (gain, 106), band pass filtered (10–
300 Hz) and recorded at 16 samples per display frame. Two
recordings were obtained from each eye per stimulus condi-
tion. Recording segments contain two or more amplifier sat-
urating artifacts were discarded.
The results of two 8-min recordings were averaged to im-
prove the signal to noise ratio. An artifact elimination tech-
nique described by Sutter and Tran was applied twice.10
For m-sequence stimulation, local first and second order
components can be derived by means of a signal cross corre-
lation between m-sequence stimulation and the response.
The first and second order components were examined.
For each stimulus area, the first order component is the dif-
ference between the mean response to all white frames in
the sequence and the mean response to all black frames
(Fig. 1). It can be described as the mean local response to
all flashes occurring in a stimulus cycle.
The second order component response represents the
temporal interaction between two focal flashes (white-
frames) separated by an integral number of stimulus base
intervals. The amplitudes and implicit times of first and sec-
ond orders were analyzed using a computer program similar
to that described by Hood and Li.13
Amplitude was calculated as the voltage difference be-
tween first trough and the first peak of the scaled template
wave. Implicit time was measured to the first prominent re-
sponse peak of the scaled template wave. This method of
determining response amplitude and implicit time is reli-
able.13–15Grading system for local characteristics of retinopathy
Stereoscopic 30 color fundus photographs were taken in
each eye. The severity of diabetic retinopathy was classified
Figure 1. (A) Patient with ERG connection; (B) patient on Ganzfeld stimulator; and (C) patient in front of MF-ERG.
MF-ERG in DM 89according to the Diabetic Retinopathy Study (DRS)16 as fol-
lows: Grade 1, indicates absence of diabetic retinopathy;
Grade 2, only microaneurysms (MAs) present (MAs definitely
other characteristics absent); Grade 3, mild to moderate non-
proliferative diabetic retinopathy (NPDR) (MAs definitely
present and any one or more of the following: venous loops,
hemorrhage, hard exudates or soft exudates definitely pres-
ent or soft exudates, intra-retinal micro-vascular abnormali-
ties (IRMA) or venous beading questionably present); Grade
4, moderate to severe NPDR (moderate to severe hemor-
rhages, MAs or IRMA definitely present); Grade 5 prolifera-
tive diabetic retinopathy (PDR). Fluorescein angiography
was used to evaluate the presence and extent of leakage.Optical coherence tomography
OCT was performed with the 3-dimensional OCT-1000
(Topcon Corp., Tokyo, Japan). OCT measurements were per-
formed using a fiberoptic optically integrated Michelson
interferometer with short coherence length superluminescent
diode.
Subjects underwent (6) linear scans spaced (30) over the
macula for measurements total retinal thickness. Internal fix-
ation (subject fixated with the eye being tested) was chosen
due to better reproducibility in our experience.
The macular thickness map was divided into nine sections
and it was displayed as three concentric circles including a
central circle, an inner ring and outer ring, with each ring di-
vided into four quadrants: superior, inferior, nasal, and tem-
poral. The central 1 mm circular region represents the
foveal region. The location of the vitreo–retinal interface
and the retinal pigment epithelium defined the inner and out-
er boundaries respectively of the retina. These two bound-
aries were associated with the sharpest edge in each OCT
scan because of the high contrast in optical reflectively be-
tween the relative non-reflective vitreous and reflective neu-
rosensory retina and between the minimally reflective outer
segments of the photoreceptors and the highly reflective ret-
inal pigment-choriocapillaris complex layer. A good quality
scan was defined as one with signal to noise ratio of more
than (50 dB). Subjects with scans that did not meet the crite-
ria of good quality scan after three attempts were excluded.Statistical analysis
Data were analyzed using SPSS version 10 (IBM Corp., NY,
USA). Quantitative data are presented as mean ± standard
deviation (SD). Chi square and test of significance were usedfor comparison between groups. Spearman’s correlation vari-
ables, RP 0.5 indicate good correlation, P 6 0.01 indicated
statistical significance.Results
A total of 128 eyes from 65 subjects were included in the
study. On ophthalmoscopic examination, 9 diabetic patients
showed no clinical signs of retinopathy whereas the remain-
ing 28 had diabetic retinopathy. Both eyes of each patient
were examined except two diabetic patient in whom the
other eye had to be excluded because of cloudy media (1
eye) and because of previous surgery (1 eye). Demographics
are included in Table 1.First order component of MF-ERG
In normal arrays, the responses were equal in height. To
compare, the wave forms between control and diabetic pa-
tients, the responses were average across all 61 local re-
sponses. Peak implicit times varied more among diabetic
subjects than among control subjects. In control subjects
the mean implicit times were (44 ± 1.0 ms) for the first posi-
tive peak (p. wave) and the mean amplitude was
(48 ± 10 nv) per degree squared. In diabetic patients without
retinopathy, mean latency of the first positive peak
(49 ± 2.0 ms) was significantly increased (P 6 0.01), the mean
amplitude (mean 47 ± 11 nv) per degree squared did not dif-
fer significantly from the Control Group (P > 0.01). In patients
with clinically apparent diabetic retinopathy, the latency of
first positive peak was significantly increased (P 6 0.01). The
amplitudes of first order component were also significantly
reduced per degree square (Table 2, Fig. 2).
First order wave forms are known to vary mainly as a func-
tion of eccentricity. Hence, responses were averaged over
concentric rings around the fovea for more accurate compar-
ison of these parameters. The results in Table 2 held true for
all eccentricities and also when first order responses were
averaged over retinal quadrants (Figs. 3–5).
There was very low inter-individual variability of implicit
time. Also, the intra-individual variability of local response im-
plicit time was small. Implicit time varied slightly with eccen-
tricity. In contrast, local response amplitudes varied to a
much greater extent both between and within normal eyes.
It is important to note the hexagonal stimuli are scaled with
retinal eccentricity to produce an approximately equal ampli-
tude response throughout the array.
Table 1. Demographic features among groups.














Grade 1 17 eyes 32–50 4 5
Grade 2 0 – – –
Grade 3 18 eyes 30–55 5 4
Grade 4 16 eyes 40–60 4 4
Grade 5 21 eyes 35–65 5 6
Table 2. First order component responses of MF-ERG among groups.
P wave latency in
millisecond (ms)
P wave amplitude in
nanovolt (nv)
Control group 44 ± 1.0 48 ± 10
P = 0.001 P = 0.002
Diabetic group P = 0.006 P = 004
Grade 1 49 ± 2.0 47 ± 11
Grade 3 51 ± 1.5 25 ± 5.0
Grade 4 53 ± 2.0 24 ± 7.0
Grade 5 60 ± 3.50 20 ± 10.0
Figure 2. Stimulus of first and second order of MF-ERG.
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nopathy were reduced relative to normal across most of the
fundus. Both ophthamloscopically normal and abnormal re-
gions within eyes with diabetic retinopathy produced MF-
ERG that were delayed relative to normal. The increased lo-
cal severity of retinopathy was associated with increased de-
lay of implicit time. No association between local MF-ERG
amplitude and retinopathy grade was apparent.Second order component of MF-ERG
The beginning of each trace of second order response
component is time locked to the beginning of the second
of the two stimuli defining the second order response com-
ponent. The mean implicit times of the control group was(38 ± 0.9 ms) for first peak. The mean amplitude was
(34 ± 4 nv). In diabetic patients without retinopathy the mean
implicit times (40 ± 3.02 ms) were significantly delayed
(P 6 0.01). The mean amplitude were (28 ± 6 nv) significantly
decreased (P 6 0.01). In diabetic patients with retinopathy,
the mean implicit times were significantly markedly delayed
(P 6 0.01). The amplitude was significantly decreased
(P 6 0.01) (Fig. 6, Table 3).Full field ERG
According to current ISCEV standard, five major ERG re-
sponses are defined: rod response, maximal combined re-
sponse and, oscillatory potential (OPs), cone response and
30-Hz flicker response. The b-wave is a large positive ERG
potential present in rod response, the maximal combined re-
sponse and photopic response.
The amplitude of the b-wave is measured from trough to
peak. Implicit time is measured from flash onset to the peak
of the b-wave.
In the Control Group, the scotopic b-wave amplitude was
75 ± 13 nv, the combined response b-wave amplitude was
200 ± 30 nv and photopic b-wave amplitude was 45 ± 9 nv.
The implicit time of the Ops waves were 23 ± 5 ms and ampli-
tude of Ops waves were 27 ± 3 nv. The implicit time of flicker
response were 50 ± 5 ms and the amplitude were 55 ± 6 nv
(Table 4, Fig. 7).
In subjects with diabetic retinopathy, there were statisti-
cally significant delays in Ops implicit time and reduction
Ops amplitude in all cases (P 6 0.001, all tests). The severity
of diabetic retinopathy correlate with the Ops amplitude
(R = 0.66, P = 0.001). A significant reduction of scotopic and
photopic b-wave amplitude, 30 Hz flicker amplitude were
found in these patients (P 6 0.001, all tests). In diabetic pa-
tients without retinopathy, there was a significant reduction
in Ops amplitude (P 6 0.001) and a significant increase
(P 6 0.001) in Ops implicit time while other parameters (phot-
opic –b-wave, scotopic b-wave, 30 Hz flicker amplitude and
implicit times) were normal (see Fig. 8).
Optical coherence tomography images showed cystoid
macular edema in 10 eyes and diffuse edema in 30 eyes.
OCT showed an increase in foveal thickness concomitant with
a clinical increase in macular edema. The implicit times of MF-
ERG were directly correlated with foveal thickness (R = 0.55,
P = 0.002) while MF-ERG amplitude and foveal thickness
were inversely correlated (R = 0.5, P = 0.001) in cases of
diabetic edema. In patients without edema there was no cor-
relation between foveal thickness and MF-ERG parameters
(R = 0.3, P = 0.1 for implicit time, R = 0.22, P = 0.01 for
amplitude).Discussion
Ocular complications due to diabetes mellitus are a major
cause of irreversible vision loss in adults in the United States.2
An objective test that can detect retinal function prior the
appearance of diabetic retinopathy, thereby identifying indi-
viduals and retinal locations at risk for development of reti-
nopathy can reduce visual morbidity.
MF–ERG technique can measure and map retinal functions
at more than 60 locations within 8 min and can distinguish
separate responses of inner and outer retina. MF-ERG has
Figure 3. First order component of MF-ERG among groups. (A) MF-ERG in control group; (B) MF-ERG in diabetic eyes with mild retinopathy in which
there is mild reduction of amplitude & delay in latency; (C) MF-ERG in late retinopathy in which no apparent peak and through; and (D) MF-ERG in
diabetic subject without retinopathy (just slight delay).
Figure 4. First order component of MF-ERG in diabetes. (A) Without retinopathy; and (B) with retinopathy.
MF-ERG in DM 91been used to examine a large number of eye diseases includ-
ing diabetes related retinal function.17
Several reports have provided information regarding reti-
nal dysfunction associated with DM. Investigators who have
analyzed MF-ERG have reported abnormally reduced ampli-
tudes and/or delayed implicit times in diabetic subjects18and in diabetic subjects without signs of retinopathy.19,20
The outcomes of the current study concurs with previous re-
ports. For example, there were reductions in the amplitudes
of first order and second order component responses and
delays in implicit times in patients with diabetic retinopathy
and macular edema. Farahvash and Mohammed Zadoh21
Figure 5. OCT in case with cystoid macula edema in which focal areas of hypo reflectivity corresponding to CMO and; three dimensional MF-ERG CMO
showing no foveal peak.
Figure 6. Three dimensional MF-ERG in diabetes. (A) Without retinopathy (in which there is foveal peak with dark areas at periphery corresponding to
affected areas); and (B) with retinopathy (in which no foveal peak with areas of decreased response corresponding to affected areas).





Control subjects 38 ± 0.9 34 ± 4
Diabetic patients
Grade 1 40 ± 2.0 28 ± 6
Grade 3 46 ± 2.5 20 ± 4.5
Grade 4 50 ± 2.8 19.9 ± 5.7
Grade 5 55 ± 3.5 18.0 ± 9.00
92 M. Abdelkaderreported that local ERG responses were significantly delayed
and decreased in amplitude in patients with significant dia-
betic edema. Similarly, Fortune et al.22 reported that implicit
times were increased and amplitudes were mildly reduced.Table 4. Full field ERG parameters among groups.
Control D
Scotopic b-wave amplitude 75 ± 13 nv
Combined b-wave amplitude 200 ± 30 nv 1
Ops
Implicit time 23 ± 5 ms
Amplitude 27 ± 3 nv
Photopic b-wave amplitude 45 ± 9 nv
30 Hz flicker
Implicit time 50 ± 5 ms
Amplitude 55 ± 6 nvGreenstein et al.23 found that implicit times were signifi-
cantly increased. Weiner et al.24 have reported that mean
amplitude of ERG was lower in eyes without diabetic edema
compared to normal eyes and was even lower in eyes with
edema.
The magnitude of MF-ERG implicit time delays was corre-
lated with the severity of retinopathy. By contrast, response
amplitude although reduced in eyes with retinopathy had
no such correlation with the degree of retinopathy in this
study. The increased implicit time of local ERG responses
were associated with increased severity of the local retinopa-
thy signs.22 Bearse et al.25 and Han et al.26 found no correla-
tion between amplitude reduction and retinal abnormalities.
ERG abnormalities can be present at a very early stage of
disease while there are no visible changes in the fundus andiabetic without retinopathy Diabetic with retinopathy
72 ± 10 nv 45 ± 20 nv
77 ± 35 nv 100 ± 50 nv
27 ± 7 ms 35 ± 10 ms
18 ± 2 nv 8 ± 5 nv
43 ± 5 nv 26 ± 12 nv
51 ± 7 ms 70 ± 10 ms
50 ± 10 nv 30 ± 15 nv
Figure 7. Second order component of MF-ERG in diabetes. (A) Without retinopathy; and (B) with late retinopathy (just irregular line with no apparent
peak through).
MF-ERG in DM 93before the onset of clinical symptoms. In this study, there
were delays in implicit times without reduction of amplitude
in the first order component, however the second order com-
ponent response was reduced in amplitude and there was an
increase in implicit times in diabetic patients without retinop-
athy. Fortune et al.22 reported that the delay in implicit times
were not only in retinal regions manifesting abnormalities but
also significantly increased in regions that appeared to be
free of fundus abnormalities on fluorescein angiography.
Weiner et al.24 found that the mean implicit time was signifi-
cantly delayed in eyes with edema while in eyes without ede-
ma, implicit times were the same as normal eyes. Fortune et
al.22 found that implicit times are often significantly delayed
in retinal location without retinopathy and in diabetic eyes
without retinopathy. Han et al.26 reported similar results of
abnormal implicit times in diabetic patients without
retinopathy.
The cause of the reduction of amplitude of second order
while the amplitude of first order was normal in early dia-
betes is likely because the first order response components
originate predominantly in the outer (cone photoreceptors)
retina and/or middle retina (cone bipolar cells, Muller cells).
Sutter and Tran10 showed that under photopic conditions,
the decreased first order response component with eccen-
tricity follows approximately that of retinal cone density. In
addition, when all the focal responses of the multifocal
cone ERG are averaged together, the response bears a
strong similarity to the full field flash ERG. Flash ERG re-
sponses originate predominantly in the outer 70% of the
retina.10 The reduced overall amplitudes and the delayed
latencies in the first order component observed in diabetic
patients with retinopathy may indicate same impairment of
outer retinal function in diabetes, although the second or-
der component of the MF-ERG contains outer retinal con-
tributions, it appears to have substantial contributions
from sources in the inner retina and also from the optic
nerve head. A response originating from nerve fibers near
the location of the optic nerve head can be extracted from
the second order component of MF-ERG. The reduction ofamplitude of second order component of MF-ERG in dia-
betic eyes without retinopathy are consistent with the pre-
vious suggestion that early diabetes causes a dysfunction
within the inner retina before photoreceptors are
affected.27,28
The cause of MF-ERG delays associated with and even
occurring before the diabetic lesion provide some insights
of the pathophysiology of the effects of diabetes on the ret-
ina. Diabetic retinopathy is a disease of small retinal vessels,
prior to the appearance of visible fundus lesions and early
characteristic changes in the retinal vasculature of diabetic
eyes there is pericyte apoptosis and basement membrane
thickening resulting in acellular capillaries.29
Three major theories have been proposed to explain how
chronic hyperglycemia and subsequent retinal hypoxia might
lead to these anatomic changes: increased formation of ad-
vanced glycosylation end products;30 abnormal bypass of
growth metabolism through the sorbitol pathway and; activa-
tion of growth factors (such as vascular endothelial growth
factor. Oxidative stress and free radical generation also pro-
motes the development of diabetic lesions.31
Compromised local metabolism may affect the function of
MF-ERG generators leading to delayed neural conduction
and prolonged implicit time. Moreover, in the diabetic eye,
early or undetected perfusion defects associated with degen-
eration of choriocapillaries may also result in implicit time de-
lays that occur before the anatomic signs of abnormal
vasculature within the inner retina.32
In contrast to the findings with implicit times, MF-ERG
amplitudes changes of first order component response were
not associated with early retinopathy. One possible reason
for the insensitivity of amplitude to diabetic dysfunction is
that this measure has larger inter-subject variability than im-
plicit time in normal subjects.
This large inter-individual variability of amplitude dimin-
ishes the usefulness of this parameter for detection of local
retinal abnormalities. In contrast, the variability in MF-ERG
implicit times was very small, consistent with the findings of
other MF-ERG studies.
Figure 8. Full field ERG among groups.
94 M. AbdelkaderAnother consideration is that amplitude measures reflect
the strength of the summed responses generated by retinal
cells and may be significantly affected only at a later stage
when the generators are severely damaged or cell loss
occurs.
Additionally it has been demonstrated that decreased
stimuli contrast or luminance affect MF-ERG amplitude tomuch greater extent than implicit time. Thus it is possible that
decreased effective stimulus contrast and/or luminance with-
in patches of retinal abnormalities may be responsible for
alteration of local MF-ERG amplitude in diabetic retinopathy
(that is absent in diabetic patients without retinopathy).33
Full field Ganzfeld ERG in the current study showed reduc-
tions in scotopic and photopic responses in diabetic patients
MF-ERG in DM 95with retinopathy. Reduction in oscillatory potential amplitude
and flicker response were also observed in those patients
with delayed implicit times. Under scotopic conditions, the
wave is directly generated by bipolar cells.34 Under photopic
conditions, several types of neurons contribute to the gener-
ation of the response.35 Ops are four to six low amplitude,
high frequency wavelets superimposed on the ascending
limb of ERG b-wave. The Ops are thought to result from
feedback between the amacrine cells and the bipolar cell
and/or feedback from ganglion cells to amacrine cells.36
Other ERG Studies of diabetic patients have reported
inconsistent results. Arden et al.37 found reduced ERG ampli-
tudes of diabetic patients only in the presence of cotton wool
spots and angiographic evidence of capillary non-perfusion
whereas others, reported normal or even supernormal ampli-
tudes in the flash ERG of diabetic patients with retinopathy.
Wanger and Persson38 could not find any flash ERG changes
that could distinguish between the presence or absence of
retinopathy in diabetic patients.
Reduction in amplitudes of oscillatory potentials have also
been reported in diabetic retinopathy.39 However, others did
not find any such changes.40
Bresnick and Palta41 and Hood and Birch42 reported that
Ops amplitudes correlate well with the severity of diabetic
retinopathy. Whereas Chung et al.43 and Satoh et al.5 ob-
served that photopic b-wave implicit times correlate well with
severity of diabetic retinopathy. In the current study, there
was a statistically significant correlation between oscillatory
potential amplitudes and severity of diabetic retinopathy
(R = 0.55, P = 0.006) while there was no correlation between
severity of diabetic retinopathy and any other parameters of
full field ERG (R = 0.2, P = 0.5).
In diabetic patients without retinopathy, there were only
changes in oscillatory potentials (reduction in amplitudes and
delay in implicit times) while other full field ERG parameters
were normal in this study. Similarly, Holopigian et al.4 and Shir-
ao and Ohta44 found that the most consistent alteration in dia-
betic eyes without retinopathy was a significant increase in the
implicit time of the oscillatory potential. Juen and Kieselbach45
and Papakostopulos et al.46 reported a significant reduction in
scotopic amplitude in diabetics without retinopathy. Cone
amplitude was also reduced in similar these cases.45,46
In the current study, there was correlation between tomo-
graphic features of OCT and MF-ERG in cases of diabetic ret-
inopathy. The implicit times of MF-ERG were positively
correlated with foveal thickness measured with OCT. The in-
creased foveal thickness was associated with increased impli-
cit times of ERG, while in cases without retinopathy there was
no correlation between OCT and MF-ERG parameters. Simi-
larly, Yamamoto et al.47 found that best corrected visual acu-
ity and macular response density of MF-ERG were inversely
correlated and implicit times were directly correlated with fo-
veal thickness.
MF-ERG is well suited to the study of diabetic retinopathy
for several reasons: Firstly, diabetic retinopathy is a retinal dis-
ease with local lesions typically confined to the posterior pole
where the MF-ERG techniques test local retinal function (the
central 45)5; Secondly, diabetic retinopathy is largely caused
by defects of retinal capillaries in the inner nuclear layer where
the cell bodies of the bipolar cells, the primary generators of
MF-ERG are located. Thus there is an anatomic basis for the
detection of MF-ERG abnormality in diabetes.MF-ERG provide very sensitive objective assessment of lo-
cal retinal health in diabetes mellitus. MF-ERG implicit time is
a sensitive measure of retinal function that can be used to
monitor the progression of diabetic retinopathy. It is evident
that, MF-ERG is abnormal very early in diabetic retinopathy.
MF-ERG can demonstrate local abnormalities while the
abnormalities in flash OPs and b-wave demonstrate the wide-
spread nature of retinopathy. ERG has several uses in diabe-
tes including: the ability to discriminate between patients
who are more likely to develop retinopathy and patients with
a lesser chance of doing so and; use as non-invasive objective
measure of the progression during follow up. The combina-
tion of MF-ERG and OCT may provide objective criteria for
the evaluation and assessment of diabetic edema.
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